Protocols of the Spanish Society of Pediatric Neurology (SENEP): Pillars of childhood neurological management

The protocols of the Spanish Society of Pediatric Neurology (SENEP) constitute a standardized and evidence-based guide for the diagnosis, management and monitoring of neurological pathologies in childhood, integrating anatomical, clinical and evolutionary aspects essential for pediatric practice. These protocols not only guide the initial evaluation, but also define personalized therapeutic strategies, identify critical points of intervention and warn about common diagnostic errors, based on neuroanatomy, developmental neurophysiology and common pathologies such as neurodevelopmental disorders, epilepsies, autism spectrum disorders (ASD) and neurometabolic diseases.

Pathophysiological and clinical basis: SENEP integrates mechanisms from early neurodevelopment to synaptic maturation, highlighting the importance of the excitatory-inhibitory balance in the infant brain. Alterations in neuronal migration, synaptogenesis or myelination—key processes during the first year of life—underlie disorders such as refractory epilepsy or motor and cognitive delays. For example, periventricular hypomyelination, detected in neuroimaging studies, correlates with deficits in connectivity of the corticospinous tract, essential for fine motor control (Battelle et al., 2020). Likewise, dysfunctions in the GABAergic pathway, with excitatory predominance in neonates, explain the subclinical hyperexcitability observed in some genetic syndromes such as Angelman syndrome or hypoxic-ischemic encephalopathies (ABD, 2021).

Evaluation and diagnostic tools: SENEP protocols emphasize diagnostic multimodality: neuroimaging (brain MRI with diffusion sequences and diffusion tensor tractography), long-term electroencephalography (EEG), and metabolic tests (ammonia, organic acids, amino acids in plasma and urine). EEG interpretation, especially in infants, requires attention to maturation: predominant syncytal activity in neonates (<6 months) contrasts with the progressive appearance of sleep waves (S1-S2) and periodic complexes, normal values ​​only up to 18-24 months (PedNIHSS, 2023). The absence of sleep waves in an infant with focal seizures should alert us to subclinical focal epilepsies or metabolic encephalopathies, where SENEP recommends genetic confirmation and metabolomics studies (Hine et al., 2022).

Therapeutic management and follow-up: Early intervention, based on standardized protocols, is essential to optimize neurological development. In childhood epilepsy, management includes first-line anticonvulsants such as phenobarbital or levetiracetam, adjusted according to clinical phenotype and pharmacogenetic profile; However, therapeutic resistance, present in ~30% of cases, requires advanced neurological evaluation and possible referral to specialized centers (SENEP, 2022). In neurometabolic disorders, such as enzyme deficiency, treatment focuses on dietary restriction (e.g., phenylalanine-free diet in PKU) and nutritional support, with strict monitoring of biochemical parameters to prevent progressive neurological damage (ABD, 2021). Neuropsychological rehabilitation, integrated from diagnosis, enhances synaptic plasticity and improves functional prognosis, especially in autism spectrum disorders, where early interventions (behavioral therapy, early stimulation) achieve significant improvements in communication and social skills (Yanez et al., 2020).

Typical cases and diagnostic pitfalls: A representative case is the 6-month-old child with focal seizures and asymmetric hypotonia: MRI reveals bilateral hippocampal atrophy, compatible with hypoxic encephalopathy, but normalization of the EEG at 3 months can confuse the prognosis if it is not correlated with clinical evolution and repeated imaging studies. Another pitfall is confusing febrile seizures with true epilepsy; here, the absence of fever during seizures and inadequate response to antipyretics should alert, while prolonged EEG may show atypical paroxysmal discharges (Hine et al., 2022). In ASD, the variable presentation makes early diagnosis difficult: an infant with poor social gaze and delayed babbling should be evaluated with scales such as M-CHAT-R and functional neuroimaging to identify alterations in frontal and temporal networks, avoiding delay in referral. Overinterpretation of normal behaviors as pathological (e.g., self-stimulation) can lead to erroneous diagnoses without rigorous differential evaluation.

Limitations and clinical context: SENEP protocols are robust tools, but not infallible; Interindividual variability in brain development and the influence of environmental factors (nutrition, exposure to toxicants) require an integrated and dynamic approach. The interpretation of biomarkers must be contextualized in gestational age, clinical chronology and functional evolution. For example, a motor delay in a 12-month-old child may be normal if associated with adequate cognitive development, but alarming if it persists without improvement, indicating alteration in motor pathways. Longitudinal follow-up, with neuropsychological evaluations every 6 months in high-risk cases, makes it possible to detect subtle delays and adjust interventions, basing the prognosis with objective data and not just clinical data (PedNIHSS, 2023).

Prognostic implications: Follow-up under SENEP protocols significantly improves neurodevelopmental prognosis: children with early diagnosis and adequate treatment show improvements in motor function, language and cognition, especially when the intervention begins before the age of 2 (SENEP, 2022). Factors such as the presence of structural brain lesions, genetic severity and family support directly influence; For example, children with hypoxic encephalopathy without structural damage have a better outcome than those with hippocampal atrophy. Brain plasticity in childhood requires timely diagnosis and multidisciplinary management to maximize functional recovery.

}
«`